» Related Searches: cancer, drug, prostate cancer, lung cancer, breast cancer
Results 21 to 30 of 68 
LONDON (Reuters) - Switching patients with early breast cancer from a standard
drug to a newer treatment helps them to live longer and improves their odds of
remaining free of … 
Synta Pharmaceuticals has said its oncology drug candidate, STA-4783, has been
granted fast track designation by the FDA for the treatment of metastatic melanoma, a
serious type of skin cancer … 
… cancer, has caused an uproar among the cancer specialists and thousands of
lung cancer patients all over England … 



LONDON (Reuters) - Switching patients with early breast cancer from a standard
drug to a newer treatment helps them to live longer and improves their odds of
remaining free of … 
Researchers in the UK and the United States have found that a drug composed of an
antibody carrying a highly toxic anti-cancer agent is well tolerated by patients at
much … 



… drug delivery vehicle that when loaded with a widely used anticancer agent cures
colon cancer in mice with a single dose … 



… drug composed of an antibody carrying a highly toxic anti-cancer agent is
well tolerated by patients at much higher doses than have been used before. [click link
for full article] … 



… cancer, according to a team of researchers in Greece, the UK, and the US. The top
contender appears to be a combination of two types of cancer drugs -- platinums … 



… cancer progression and treatment resistance. Two studies in the November 2006
issue of the journal Cancer Cell, published by Cell Press, provide mechanistic
details that may explain why the small-molecule … 



The Food and Drug Administration may be on the verge of approving a new use for
Herceptin, a bioengineered drug used to treat breast cancer. The Early Show
medical correspondent … 